INSULINX Trademark

Trademark Overview

On Thursday, September 2, 2010, a trademark application was filed for INSULINX with the United States Patent and Trademark Office. The USPTO has given the INSULINX trademark a serial number of 85121674. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 5, 2019. This trademark is owned by Abbott Diabetes Care Inc.. The INSULINX trademark is filed in the Medical Instrument Products category with the following description:

Medical instruments for use in monitoring blood glucose
insulinx

General Information

Serial Number85121674
Word MarkINSULINX
Filing DateThursday, September 2, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 5, 2019
Registration Number4202868
Registration DateTuesday, September 4, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2011

Trademark Statements

Goods and ServicesMedical instruments for use in monitoring blood glucose
Pseudo MarkINSULIN X

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2019
Primary Code010
First Use Anywhere DateFriday, May 6, 2011
First Use In Commerce DateWednesday, April 18, 2012

Trademark Owner History

Party NameAbbott Diabetes Care Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAlameda, CA 94502
Party NameAbbott Diabetes Care Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAlameda, CA 94502
Party NameAbbott Diabetes Care Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlameda, CA 94502

Trademark Events

Event DateEvent Description
Friday, April 5, 2019CANCELLED SEC. 8 (6-YR)
Monday, September 4, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 4, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, July 31, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, July 28, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, July 20, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 10, 2012STATEMENT OF USE PROCESSING COMPLETE
Friday, June 29, 2012USE AMENDMENT FILED
Friday, June 29, 2012TEAS STATEMENT OF USE RECEIVED
Friday, May 4, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 3, 2012EXTENSION 2 GRANTED
Tuesday, April 10, 2012EXTENSION 2 FILED
Wednesday, May 2, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 10, 2012TEAS EXTENSION RECEIVED
Friday, March 9, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 9, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 22, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 20, 2011EXTENSION 1 GRANTED
Tuesday, September 20, 2011EXTENSION 1 FILED
Tuesday, September 20, 2011TEAS EXTENSION RECEIVED
Tuesday, September 20, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 20, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 12, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 15, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2011PUBLISHED FOR OPPOSITION
Monday, January 10, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 10, 2011ASSIGNED TO LIE
Tuesday, December 14, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 14, 2010ASSIGNED TO EXAMINER
Wednesday, September 8, 2010NOTICE OF PSEUDO MARK MAILED
Tuesday, September 7, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 6, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

insulinx glucose blood monitoring instruments medical